GRACE THOMPSON BELL: Open Payments
NPI 1720544091 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,814 in 69 payments from 32 companies in 2025. Trend: 2023 $1,462 · 2024 $454 · 2025 $1,814
Food & beverage: $1,636Education: $178
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $301 |
| GENZYME CORPORATION | 2 | $127 |
| Lilly USA, LLC | 2 | $126 |
| AstraZeneca Pharmaceuticals LP | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| Merck Sharp & Dohme LLC | 4 | $97 |
| BeOne Medicines USA, Inc. | 3 | $72 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Eisai Inc. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
Products named: ERLEADA, JAYPIRCA, KEYTRUDA, Lenvima, LIBTAYO, ICLUSIG, CABOMETYX, Venclexta.
Industry payments across CA — which companies pay providers there.
